NasdaqGS:LFSTHealthcare
A Look At LifeStance Health Group (LFST) Valuation After Earnings Beat Guidance Upgrade And $100m Buyback
What just happened with LifeStance Health Group stock?
LifeStance Health Group (LFST) just reported fourth quarter and full year 2025 results, moved from a net loss to net income, issued 2026 revenue guidance, and announced a US$100 million share repurchase program.
See our latest analysis for LifeStance Health Group.
The recent earnings beat, move to net income, 2026 revenue guidance and US$100 million buyback plan have coincided with a 12.96% 90 day share price return to US$7.41. This comes...